Oxford Gene Technology
Suite 500
Tarrytown, NY 10591
Share:
New Constitutional NGS Panel Comes with Interpret Software
Enables accurate and comprehensive constitutional genetic aberration screening. Designed to be run on Illumina NextSeq™ or NovaSeq™. Includes hybridisation capture baits, and library preparation kit.
Read More »
New SureSeq CLL + CNV Panel for Research into Chronic Lymphocytic Leukaemia
Fulfils the need for reliable (CNV) detection by NGS, including trisomy 12 and loss of heterozygosity (LOH) as well as somatic variants even at low allele frequency. Covers up-to-date, evidence-based genes and genomic aberrations for CLL and will enable laboratories to simplify their laboratory workflow by replacing multiple assays with a single one. Simplifies the workflow and consolidates...
Read More »
New CytoSure NGS Panel Available with Interpret Analysis Software
Enables accurate and confident detection of loss of heterozygosity, mosaicism and copy number variants. Meet the increasing desire of labs to transition from microarrays to NGS and obtain as much information as possible from a single assay. Combines the strengths of microarrays and NGS to deliver a comprehensive all-in-one assay.
Read More »
OGT Expands SureSeq Portfolio with Complete Library Preparation Solution
Updates and refines the library preparation workflow including the addition of automation support. Features ready-to-use hybridisation and wash buffer. Provides easy access to all of the benefits of hybridisation while breaking down the barriers to its implementation.
Read More »
Latest SureSeq Interpret NGS Analysis Software is Designed for Mutation Detection and Analysis
The SureSeq™ Interpret NGS Analysis Software is designed for analysis and visualisation of single nucleotide variants, Indels, copy number variants and internal tandem duplications. This software processes sequencing data and delivers mutation calling at an accuracy of 100% and specificity of 99.9% at 1% variant allele frequency. SureSeq’s customisation options allow user to tailor variant...
Read More »
PGS Array optimizes embryo screening for IVF.
Offering 8 arrays of 60,000 spots, CytoSure™ Embryo Screen Array supports high-resolution genome-wide aneuploidy and copy number detection in pre-implantation embryos. Microarray can screen up to 14 embryos on single slide, which is particularly useful in embryo banking. For optimal hybridization and maximum accuracy, probe design exactly mirrors only amplified DNA; regions of genome that have...
Read More »OGT Pledges Partnership with Significant Brand Refresh and Integration
Oxford, UK – 24 March 2021. OGT, a Sysmex Group Company, is today unveiling a brand refresh and new integrated website that reaffirms and pledges its commitment to delivering partnership, innovation and expertise to scientists and clinical decision makers worldwide. The new integrated website reflects this commitment by delivering substantial resources, support and tools along with an...
Read More »
New Constitutional NGS Panel Comes with Interpret Software
Enables accurate and comprehensive constitutional genetic aberration screening. Designed to be run on Illumina NextSeq™ or NovaSeq™. Includes hybridisation capture baits, and library preparation kit.
Read More »
New SureSeq CLL + CNV Panel for Research into Chronic Lymphocytic Leukaemia
Fulfils the need for reliable (CNV) detection by NGS, including trisomy 12 and loss of heterozygosity (LOH) as well as somatic variants even at low allele frequency. Covers up-to-date, evidence-based genes and genomic aberrations for CLL and will enable laboratories to simplify their laboratory workflow by replacing multiple assays with a single one. Simplifies the workflow and consolidates...
Read More »
New CytoSure NGS Panel Available with Interpret Analysis Software
Enables accurate and confident detection of loss of heterozygosity, mosaicism and copy number variants. Meet the increasing desire of labs to transition from microarrays to NGS and obtain as much information as possible from a single assay. Combines the strengths of microarrays and NGS to deliver a comprehensive all-in-one assay.
Read More »
OGT Expands SureSeq Portfolio with Complete Library Preparation Solution
Updates and refines the library preparation workflow including the addition of automation support. Features ready-to-use hybridisation and wash buffer. Provides easy access to all of the benefits of hybridisation while breaking down the barriers to its implementation.
Read More »OGT Celebrates Opening of New Cambridge Site
State-of-the-art premises increases operational footprint and will host Sysmex global R&D facility Oxford, UK – 6 June 2019. Oxford Gene Technology (OGT), A Sysmex Group Company, has celebrated the opening of its new facility in Cambridge, UK. The opening ceremony, which took place on 3rd June at the company’s new premises on the prestigious Cambridge Science Park, was attended by the...
Read More »OGT to Open New Cytocell Facility in Cambridge, UK
Sysmex demonstrates confidence and investment in OGT and the United Kingdom Oxford, UK – 26 February 2019. Oxford Gene Technology (OGT), The Molecular Genetics Company, has announced that it is expanding its Cytocell® operations with a move to a new facility in Cambridge, UK. Cytocell, OGT’s fluorescence in situ hybridisation (FISH) probe brand, will be moving into the significantly larger...
Read More »
Latest SureSeq Interpret NGS Analysis Software is Designed for Mutation Detection and Analysis
The SureSeq™ Interpret NGS Analysis Software is designed for analysis and visualisation of single nucleotide variants, Indels, copy number variants and internal tandem duplications. This software processes sequencing data and delivers mutation calling at an accuracy of 100% and specificity of 99.9% at 1% variant allele frequency. SureSeq’s customisation options allow user to tailor variant...
Read More »OGT Expands Direct Sales and Support Infrastructure in Europe
Customers to benefit from Sysmex’s extensive operational footprint Oxford, UK – 3rd July 2018. Oxford Gene Technology (OGT), The Molecular Genetics Company, has announced that it is now directly selling Cytocell Fluorescence In Situ Hybridisation (FISH) products through several established affiliates of Sysmex Corporation in Europe following its acquisition last year. The move is a testament...
Read More »OGT Announces Organisational Changes
Appointments strengthen push into molecular diagnostics Oxford, UK – 9 April 2018. Oxford Gene Technology (OGT), The Molecular Genetics Company, has announced that on 1st April 2018 Dr John Anson who has been with the company since 2006 as EVP of R&D took over as CEO from Dr Mike Evans, who has become a non-executive director of OGT’s board. In addition, as part of the company’s increasing...
Read More »